Drew Spaventa is the founder of Singular Genomics. Singular Genomics has raised $384M in total funding. Latest round: IPO.
Drew Spaventa is the CEO of Singular Genomics, a DNA sequencing company co-founded in 2017 (or 2014) in San Diego, California. He led the company from a seed round to a public listing on Nasdaq in 2021, and its first benchtop sequencer, the G4, was launched under his leadership in December 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library